Natural Supplements for Dogs With Epilepsy: Safety

What does “natural support” mean for a dog with epilepsy?

Natural support means discussing a possible addition to a dog’s care plan while the veterinary team continues to evaluate and manage the underlying seizure disorder. It does not mean that an ingredient treats epilepsy simply because it comes from a plant, food, mineral, oil, or other naturally occurring source.

A seizure is a sudden burst of abnormal electrical activity in the brain that can cause changes in movement, awareness, behavior, sensation, or body function. A dog may stiffen, paddle, fall, lose awareness, vocalize, drool, urinate, or show subtle changes that are easy to miss. Some dogs seem confused, restless, hungry, tired, or unsteady after the event.

Epilepsy describes a tendency to have recurrent unprovoked seizures. Idiopathic epilepsy is a diagnosis made after other possible causes have been considered or ruled out. Those causes can include metabolic disease, toxins, inflammation, structural brain disease, or other disorders. Cornell University College of Veterinary Medicine explains that the evaluation may involve a history, neurologic examination, blood and urine testing, and, when indicated, advanced testing such as MRI or cerebrospinal-fluid analysis. See the Cornell guidance on idiopathic epilepsy in dogs for that diagnostic context.

An antiseizure medication, sometimes called an anticonvulsant, is a prescription medicine used to reduce seizure activity or make seizures less severe or less frequent. These medicines can have their own benefits, risks, laboratory-monitoring needs, and adjustment schedules. A new supplement enters that same clinical picture.

That distinction matters because a caregiver may reasonably want to support a dog’s comfort, nutrition, digestion, liver health, or overall wellbeing. Those goals deserve a veterinary conversation. They should remain separate from claims that a product can control epilepsy, prevent seizures, cure a neurologic disorder, or make prescribed treatment unnecessary.

The U.S. Food and Drug Administration explains that products used in animals do not receive a special dietary-supplement category under the human Dietary Supplement Health and Education Act. Depending on a product’s composition and intended use, it may be treated as animal food or as an animal drug. Disease-treatment claims can carry regulatory significance. The FDA also reported warning six sellers on January 7, 2025, over unapproved seizure products marketed for animals. That action does not prove that every supplement is unsafe, but it is a useful reason to look past marketing language and examine the product’s actual claims and label.

A practical rule is simple:

Treat “natural” as a description of origin, not as proof of safety, effectiveness, purity, or medication compatibility.

Why do supplements require a medication and health-history review?

Supplements deserve the same careful review as other active substances because their ingredients can affect sedation, digestion, liver metabolism, nutrient balance, blood testing, appetite, or the action of a prescribed medication. The possible risk depends on the specific product and the dog receiving it.

A product may contain one active ingredient or a mixture of herbs, oils, vitamins, minerals, extracts, flavorings, preservatives, and other components. The label may state the amount of a plant or extract without clearly stating the amount of the active compound. A serving may be expressed by body weight, scoop, dropper, capsule, or volume. Those details affect what the veterinarian can evaluate.

Product quality also matters. Two products with similar front-label wording may differ in:

• Ingredient identity and species
• Extract strength or chemical form
• Amount per serving
• Batch consistency
• Contaminant testing
• Storage stability
• Added ingredients
• Intended use and disease claims

A dog’s health history changes the review as well. The veterinarian may need to consider age, breed, body weight, liver or kidney disease, gastrointestinal disease, pregnancy status, diet, prior reactions, other prescriptions, nonprescription products, and the pattern of seizure activity.

The word interaction means that one substance changes the effect, concentration, absorption, metabolism, or side-effect profile of another. An interaction can make a medication less effective, increase sedation, alter laboratory results, or create a new adverse effect. The absence of a warning on a product page does not establish that no interaction exists.

Our broader guide to pet supplement interactions with medications explains why the exact ingredient, serving, medication, medical history, and timing matter. The same principle applies with particular force when a dog already has a neurologic condition and receives medication intended to control seizures.

What should caregivers know about phenobarbital?

Phenobarbital is a commonly used first-line antiseizure medication in dogs. It can cause sedation, unsteadiness, increased thirst or urination, increased appetite, changes in liver-related laboratory values, and other effects that require veterinary interpretation. Merck Veterinary Manual describes an approximate two-to-three-week period for phenobarbital to reach steady state, meaning a relatively stable blood concentration after regular dosing. It also describes serum concentration monitoring and attention to liver health.

Those details are not a dosing guide. A caregiver should never use a supplement article to start, stop, increase, decrease, or substitute phenobarbital. They do show why a new product should be disclosed before use. If a dog becomes sleepy, wobbly, less coordinated, unusually hungry, unusually thirsty, vomiting, or behaviorally different after a change, the veterinarian needs to know the timing of the change and the complete list of exposures.

The 2023 controlled CBD study in dogs with drug-resistant idiopathic epilepsy also identified an unresolved question about chronic CBD and phenobarbital pharmacokinetics, meaning how the body absorbs, distributes, changes, and removes those substances. The study authors recommended monitoring liver enzymes and bile acids during chronic CBD administration. That finding does not prove that CBD creates the same interaction in every dog. It does show why a retail hemp or CBD product should not be treated as interchangeable with the preparation used in a study.

Why does potassium bromide require special consistency?

Potassium bromide is another antiseizure treatment used in some dogs. Bromide concentrations can be affected by changes in dietary salt or chloride intake. Increased chloride can promote bromide excretion and lower the bromide concentration, while reduced chloride can raise it. For that reason, sudden diet changes deserve attention.

Veterinary guidance also advises reviewing potassium bromide alongside sedating drugs, diuretics, drugs that may lower the seizure threshold, and all supplements or herbal products. The practical message is broader than “check whether the supplement contains salt.” A product may affect the dog through another ingredient, a gastrointestinal change, appetite changes, altered diet, or additive sedation.

VCA’s client guidance on bromides and potassium bromide monitoring recommends disclosing supplements and maintaining veterinary oversight. The exact monitoring schedule varies with the dog and the clinical reference used, so the prescribing veterinarian should determine what testing and follow-up are appropriate.

Never stop potassium bromide abruptly unless the veterinarian gives specific instructions. A supplement should not be used as a reason to change the prescribed treatment plan.

What evidence exists for supplements used with canine epilepsy?

The strongest evidence in the supplied research concerns selected, defined preparations studied as additions to existing antiseizure treatment. It does not support a universal recommendation for herbs, vitamins, minerals, oils, or multi-ingredient products.

That distinction is easy to lose in online discussions. A study of one controlled formulation does not establish that every retail product with a similar front-label ingredient has the same dose, purity, absorption, or clinical effect.

Medium-chain triglycerides

Medium-chain triglycerides, or MCTs, are a group of fats with a particular chain length. A six-month multicenter randomized, double-blinded, placebo-controlled crossover trial studied a defined MCT dietary supplement in dogs with idiopathic epilepsy already receiving antiseizure drugs.

In the analyzed study population, the median seizure frequency was 2.51 seizures per month during the MCT phase compared with 2.67 seizures per month during the control phase. Median seizure-day frequency was 1.68 days per month during the MCT phase compared with 1.99 days per month during the control phase. The trial enrolled 28 dogs and reported 21 dogs in the analyzed six-month crossover trial.

Those results are relevant, but their boundaries matter:

• The dogs had a defined form of idiopathic epilepsy and were receiving antiseizure medication.
• The researchers studied a specified preparation under controlled conditions.
• The trial does not establish that ordinary MCT oil has the same composition, purity, serving, or effect.
• The study does not support replacing antiseizure medication.
• The sample was small, and the results may not apply to every cause of seizures or every seizure pattern.

This is an example of adjunctive evidence: evidence about an addition to existing treatment. It is not evidence that a supplement can stand alone.

Cannabidiol and CBD products

Cannabidiol, or CBD, is a compound found in cannabis plants. The available canine epilepsy studies provide conditional and mixed evidence, with safety and interaction questions that remain important.

A 2019 randomized blinded controlled trial included 26 client-owned dogs with intractable idiopathic epilepsy. The study assessed CBD oil added to conventional antiseizure treatment. The reported median seizure-frequency reduction was 33% in the CBD group, yet the responder proportions did not differ between groups. Two dogs receiving CBD were withdrawn because of ataxia, meaning impaired coordination, and increased serum alkaline phosphatase was reported.

A 2023 double-blinded crossover study included 51 dogs with drug-resistant idiopathic epilepsy receiving concurrent antiseizure medication. During the 9 mg/kg/day CBD phase, seizure days decreased by 24.1%, compared with a 5.8% increase during the placebo phase. The study did not find a significant difference in responder rate. Liver enzymes increased, and decreased appetite and vomiting were more common with CBD.

These findings do not establish that CBD is universally effective or safe. The studies used specified preparations and controlled research conditions. Retail products can differ in concentration, purity, cannabinoid content, contaminants, and labeling accuracy. The studies also evaluated CBD as an addition to existing medication, not as a replacement.

The 2019 trial is available through the PubMed record for the controlled canine CBD study. The 2023 study is available as the full Journal of Veterinary Internal Medicine CBD study. Each paper should be read within its own population, preparation, dose, duration, and limitations.

What about other herbs, vitamins, minerals, and oils?

The supplied clinical evidence does not establish broad safety or efficacy for every other category of supplement marketed for dogs with seizures. That includes combination herbal formulas, calming products, concentrated oils, vitamins, minerals, adaptogens, mushroom products, and human supplements.

A product may have a plausible biological explanation and still lack useful evidence in dogs with epilepsy. A mechanism is a proposed way an ingredient could affect the body. It is not the same as a demonstrated clinical benefit.

Our educational article on adaptogens and what canine studies show explains why evidence can vary by extract, dose, dog population, and outcome. A separate guide to human supplements for dogs covers why a human serving cannot be transferred directly to a dog.

The careful conclusion is that a supplement may be worth discussing, but the evidence must be matched to the actual ingredient, formulation, amount, disease context, and medication plan.

Is the product label complete enough for a veterinary review?

A label is ready for meaningful review when it identifies the product clearly, lists all ingredients and amounts, explains the serving information, and gives enough manufacturer detail for the veterinarian to assess what the dog would receive. If key information is missing, pause before giving the product.

Bring the original container or clear photographs of every label panel. Online product pages can change, and a front label alone rarely provides enough information.

Look for the following:

Be cautious when a product uses phrases such as “replaces seizure medication,” “guaranteed seizure control,” “works for every dog,” or “no side effects.” Those claims go far beyond what the supplied evidence supports. The FDA explains the regulatory importance of expressed or implied claims to cure, treat, prevent, or mitigate disease in animals.

A missing amount is a meaningful missing fact. So is a proprietary blend that gives a total weight but does not disclose the amount of each ingredient. The label may still be legitimate, but the veterinarian has less information with which to assess risk.

For a deeper label-focused framework, review ingredient form, nutrient amounts, and contaminant questions for canine supplements. The article is general education and does not establish that any specific product is appropriate for a dog with epilepsy.

What should you bring to the veterinary appointment?

The most useful appointment begins with organized information. Your veterinarian can make a more precise assessment when the product label, medication list, seizure history, and health changes are visible together.

Bring:

• The complete supplement container or photographs of all label panels
• The product website or manufacturer information, if available
• Every prescription medication, including dose and schedule
• Over-the-counter medicines, vitamins, oils, treats, and herbal products
• The dog’s current diet and any recent diet changes
• The date of the last veterinary examination
• Recent bloodwork or drug-concentration results, if available
• A seizure diary or written seizure history
• Videos of unusual events, when safely recorded
• Questions about the purpose, expected benefit, risks, and monitoring plan

Write down the exact product name. Many products have similar names, and a small difference in formulation can change the review.

Also write down what you hope the supplement will accomplish. “I want to support liver health,” “I want to reduce sedation,” and “I want to reduce seizure frequency” are different goals that require different discussions. A clear goal helps the veterinarian explain what the product can and cannot reasonably be expected to do.

If the diagnosis is uncertain, ask whether additional evaluation is needed before discussing supplements. If seizures are difficult to control, ask whether referral to a veterinary neurologist would be useful. Specialist input can be valuable when the diagnosis, medication plan, or seizure pattern is complicated.

Early review checklist

Use this checklist before contacting the veterinary team:

• I have the full product label, including active and inactive ingredients.
• I know the amount per serving and the serving directions.
• I have recorded the product name, manufacturer, lot number, and expiration date when available.
• I have listed every prescription, over-the-counter product, vitamin, oil, herb, and treat.
• I know the dog’s current diet and recent changes.
• I have written down the reason I am considering the supplement.
• I have recorded recent seizure dates, duration, number, and recovery.
• I have noted any recent vomiting, diarrhea, appetite change, sedation, unsteadiness, or behavior change.
• I understand that the veterinarian must decide whether the product fits this dog’s care plan.

This checklist cannot determine safety by itself. It helps show whether the information needed for a safe discussion is complete.

How should you introduce and monitor a veterinarian-approved change?

After the veterinarian reviews the product, agree on the introduction plan before giving the first serving. The plan should be specific to the dog, ingredient, medication combination, diagnosis, and health history.

Ask the veterinarian to define:

1. Whether the product should be used at all.
2. The exact product and serving instructions.
3. Whether it should be introduced gradually or started in another way.
4. What time of day it should be given.
5. Which prescribed medications must remain unchanged.
6. Which signs are expected, possible, or concerning.
7. Whether bloodwork or drug-concentration testing is needed.
8. How long the veterinarian wants observations recorded.
9. When to call the clinic.
10. What to do if a dose is missed or the dog vomits.

There is no universal monitoring duration or universal supplement dose that applies to every dog with epilepsy. The observation period depends on the product, the reason for use, the dog’s baseline seizure pattern, concurrent medication, organ function, and the veterinarian’s clinical judgment.

The safest monitoring approach changes one meaningful variable at a time whenever the veterinarian agrees that this is appropriate. Starting several supplements together makes it harder to identify which change preceded an improvement, side effect, or seizure change. It also makes the veterinary review less precise.

During the agreed observation period, keep the dog’s prescribed medication schedule consistent unless the veterinarian directs a change. Avoid changing the diet, treats, exercise routine, and other supplements at the same time if those changes can reasonably be postponed. Potassium bromide is one reason diet consistency may matter.

A supplement should be stopped or withheld only according to the veterinarian’s instructions, unless the dog is experiencing an urgent reaction and the veterinary team gives different immediate guidance. Do not make medication changes based solely on a supplement company’s recommendation.

What should a seizure and supplement diary record?

A seizure and supplement diary should record observable facts and timing so the veterinarian can compare the dog’s baseline with what happened after a change. It can show that two events occurred near each other in time. It cannot prove that a supplement caused an improvement or deterioration.

Record each event as soon as practical. Avoid writing conclusions such as “the supplement caused the seizure” or “the supplement worked.” Write what you saw.

A video can help the veterinarian distinguish a seizure from other events, but safety comes first. Do not restrain the dog, place anything in the mouth, or delay emergency care to record a video.

A diary is most useful when it is consistent. The same simple format used every day is often more valuable than a detailed account written only after a frightening event. Keep the record available on your phone and bring it to appointments.

For additional background on documenting changes, our canine health and medication safety guidance discusses diagnosis-first supplement decisions and why laboratory changes need clinical interpretation. Liver-related monitoring can be especially relevant when a dog receives phenobarbital or when a veterinarian is evaluating a product that may affect liver enzymes.

When should routine monitoring become urgent?

A seizure lasting more than five minutes, multiple seizures within 24 hours, ongoing seizure activity, or failure to recover as expected requires immediate veterinary assessment. Do not wait for a supplement to act during a seizure emergency.

Status epilepticus refers to prolonged or repeated seizure activity that requires emergency treatment. The 2024 American College of Veterinary Internal Medicine consensus statement uses five minutes as a key threshold for status-epilepticus decision-making. Cluster seizures are multiple seizures occurring within a defined period, commonly multiple seizures in 24 hours. Cornell’s client guidance also identifies a seizure lasting more than five minutes or multiple seizures within 24 hours as an emergency concern.

Contact an emergency veterinary hospital promptly if:

• A seizure lasts longer than five minutes.
• Another seizure occurs before the dog has recovered.
• The dog has multiple seizures within 24 hours.
• Seizure activity continues or repeatedly returns.
• The dog has difficulty breathing, severe injury, collapse, or prolonged unresponsiveness.
• A suspected supplement reaction causes severe weakness, repeated vomiting, marked unsteadiness, breathing difficulty, facial swelling, or another rapidly worsening sign.
• You are uncertain whether the event is a seizure or whether the dog is recovering normally.

If your veterinarian has provided a home rescue-medication plan, follow that plan exactly. Do not improvise a rescue dose from a supplement, human medication, or another pet’s prescription.

During a seizure, move nearby objects away, keep the dog away from stairs and water, reduce noise and light when possible, and time the event. Do not place your hands near the mouth. Once the event ends, call the veterinary team for guidance if the event was unusual, prolonged, repeated, or followed by concerning signs.

What questions should you ask before adding anything?

Specific questions help turn a general product discussion into an individualized care review.

Ask about the diagnosis:

• Has my dog’s seizure cause been evaluated sufficiently?
• Does the history suggest idiopathic epilepsy, or are other causes still being considered?
• Would a veterinary neurologist referral help?
• Which changes in seizure pattern should prompt reassessment?

Ask about the supplement’s purpose:

• What is the intended goal of this product?
• Is that goal separate from treating epilepsy?
• Is there meaningful canine evidence for this exact ingredient and formulation?
• What would count as a realistic benefit?
• What would count as a reason to stop or reassess?

Ask about the label:

• Are all active and inactive ingredients identified?
• Is the amount of each active ingredient clear?
• Does the serving information make sense for my dog’s weight and health history?
• Are there concerns about extract strength, contaminants, or quality testing?
• Do the product claims go beyond the available evidence?

Ask about medication compatibility:

• Could this product add to sedation or unsteadiness?
• Could it affect liver enzymes, drug metabolism, appetite, digestion, or blood testing?
• Does it raise concerns with phenobarbital, potassium bromide, or another antiseizure medication?
• Should diet, salt intake, treats, or dosing times remain consistent?
• Does the dog need a baseline or follow-up laboratory test?

Ask about monitoring:

• What should I record each day?
• How long should I observe the change?
• Which signs require a routine call, same-day evaluation, or emergency care?
• Should I introduce one change at a time?
• What should I do if my dog vomits the product or misses a prescribed medication?

A veterinarian may not be able to answer every question from a front label alone. That is a reason to request complete manufacturer information or choose not to proceed until the product can be evaluated.

Natural supplement decisions: a safer comparison

The comparison below helps separate common approaches to the decision. It does not rank products or declare any ingredient safe.

The most reliable decision point is not the product’s marketing promise. It is whether the veterinary team has enough accurate information to assess the dog, the product, and the current treatment plan together.